Institute of Urology, Department of Nuclear Medicine, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Urol. 2011 Aug;186(2):436-41. doi: 10.1016/j.juro.2011.03.121. Epub 2011 Jun 15.
11C-choline was postulated to provide better diagnostic capabilities than other tracers used in positron emission tomography/computerized tomography for staging urothelial carcinoma. We compared the value of using 11C-choline with the well investigated 18F-FDG tracer in this setting.
The study group included 20 consecutive patients with bladder cancer who underwent evaluation for local and metastatic disease using 11C-choline and 18F-FDG positron emission tomography/computerized tomography. Patients were treated with radical cystectomy with lymph node dissection, radiation therapy or chemotherapy independent of positron emission tomography/computerized tomography results. The histopathological findings (when available), followup positron emission tomography and radiological imaging served as the reference standard. Using the paired t test we compared the maximum standardized uptake and lesion-to-background ratio of the tracers. The positive predictive values were determined.
A total of 51 lesions showed abnormal tracer activity. The positive predictive value for all detected lesions was 84.7% for 11C-choline positron emission tomography/computerized tomography and 90.7% for 18F-FDG positron emission tomography/computerized tomography. The corresponding positive predictive values for extravesical lesions were 79.4% and 88.2%, respectively. Discrepant findings between the tracers were noted at 11 sites. 18F-FDG positron emission tomography/computerized tomography correctly identified 4 extravesical metastases missed by choline positron emission tomography/computerized tomography in the absence of a contrary observation. Mean maximum standardized uptake and lesion-to-background ratio at extravesical sites were significantly higher for FDG.
Within the limitations of a relatively small number of patients and partial histopathological analysis, 11C-choline positron emission tomography/computerized tomography appears to have no advantage compared to 18F-FDG positron emission tomography/computerized tomography in the detection of metastatic bladder cancer. 18F-FDG positron emission tomography/computerized tomography has a tendency toward greater accuracy.
11C-胆碱被认为比正电子发射断层扫描/计算机断层扫描中用于分期尿路上皮癌的其他示踪剂具有更好的诊断能力。我们比较了在这种情况下使用 11C-胆碱和经过充分研究的 18F-FDG 示踪剂的价值。
研究组包括 20 例连续的膀胱癌患者,他们使用 11C-胆碱和 18F-FDG 正电子发射断层扫描/计算机断层扫描进行局部和转移性疾病的评估。患者接受根治性膀胱切除术和淋巴结清扫术、放疗或化疗,无论正电子发射断层扫描/计算机断层扫描结果如何。组织病理学发现(如有)、随访正电子发射断层扫描和影像学检查作为参考标准。我们使用配对 t 检验比较了示踪剂的最大标准化摄取和病变与背景的比值。确定了阳性预测值。
共发现 51 个病变有异常示踪剂活性。11C-胆碱正电子发射断层扫描/计算机断层扫描对所有检测到的病变的阳性预测值为 84.7%,18F-FDG 正电子发射断层扫描/计算机断层扫描为 90.7%。对于膀胱外病变,相应的阳性预测值分别为 79.4%和 88.2%。在 11 个部位观察到示踪剂之间的不一致发现。18F-FDG 正电子发射断层扫描/计算机断层扫描正确识别了 4 个胆碱正电子发射断层扫描/计算机断层扫描遗漏的膀胱外转移灶,而没有相反的观察结果。FDG 在膀胱外部位的平均最大标准化摄取和病变与背景的比值明显更高。
在患者数量相对较少和部分组织病理学分析的限制下,与 18F-FDG 正电子发射断层扫描/计算机断层扫描相比,11C-胆碱正电子发射断层扫描/计算机断层扫描在检测转移性膀胱癌方面似乎没有优势。18F-FDG 正电子发射断层扫描/计算机断层扫描具有更高的准确性倾向。